References

Interstitial lung disease: a review

10.1001/jama.2024.3669 · 2024 · External reference

Association between interstitial lung abnormalities and all-cause mortality

10.1001/jama.2016.0518 · 2016 · External reference

High-attenuation areas on chest computed tomography and clinical respiratory outcomes in community-dwelling adults

10.1164/rccm.201703-0555oc · 2017 · External reference

Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society

10.1016/s2213-2600(20)30168-5 · 2020 · External reference

Development and progression of interstitial lung abnormalities in the Framingham Heart Study

10.1164/rccm.201512-2523oc · 2016 · External reference

Overlap of genetic risk between interstitial lung abnormalities and idiopathic pulmonary fibrosis

10.1164/rccm.201903-0511oc · 2019 · External reference

Imaging patterns are associated with interstitial lung abnormality progression and mortality

10.1164/rccm.201809-1652oc · 2019 · External reference

10.1093/ajrccm/aamag075 · 2026 · Admitted local publication

Progressive early interstitial lung abnormalities in persons at risk for familial pulmonary fibrosis: a prospective cohort study

10.1164/rccm.202403-0524oc · 2024 · External reference

A Bayesian disease progression model for clinical trajectories

2018 · External reference

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

10.1016/s0140-6736(11)60405-4 · 2011 · External reference

Meaningful endpoints for idiopathic pulmonary fibrosis (IPF) clinical trials: emphasis on ‘feels, functions, survives’. Report of a collaborative discussion in a symposium with direct engagement from representatives of patients, investigators, the national institutes of health, a patient advocacy organization, and a regulatory agency

10.1164/rccm.202312-2213so · 2024 · External reference